Search Results - "Chaves, Daniel G"

Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A by Zuccherato, Luciana W, Elói-Santos, Silvana M, Jardim, Letícia L, Camelo, Ricardo M, Chaves, Daniel G, Souza, Renan P, Hollox, Edward J, Rezende, Suely M

Get full text

Germline variants of the immune checkpoint proteins PD‐1, PD‐l1 and CTLA‐4 and immune tolerance induction outcome in patients with inherited haemophilia A by Zuccherato, Luciana W., Camelo, Ricardo M., Chaves, Daniel G., Rezende, Suely M.

Get full text

Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study by Jardim, Letícia L., Santana, Marcio P., Chaves, Daniel G., van der Bom, Johanna, Rezende, Suely M.

“…Up to 35% of patients with hemophilia A and 5% with hemophilia B develop neutralizing antibodies which can inhibit the therapeutic activity of factor…”
Get full text

Prevalence of sporadic haemophilia A by Santana, Márcio A. P., Chaves, Daniel G., Camelo, Ricardo M., Zuccherato, Luciana W., Jardim, Letícia L., Rezende, Suely M.

Get full text

HCV infection in hemophilia A patients is associated with altered cytokines and chemokines profile and might modulate the levels of FVIII inhibitor by Bolina‐Santos, Eduarda, Chaves, Daniel G., Silva‐Malta, Maria C. F., Carmo, Ricardo A., Barbosa‐Stancioli, Edel F., Lobato Martins, Marina

“…Prevalence of hepatitis C virus (HCV) is high in hemophilia A patients and the development of FVIII inhibitor is another challenge in the management of these…”
Get full text

Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study by Jardim, Letícia L., Chaves, Daniel G., Silveira‐Cassette, Amanda C. O., Simões e Silva, Ana Cristina, Santana, Marcio P., Cerqueira, Monica H., Prezotti, Alessandra, Lorenzato, Claudia, Franco, Vivian, Bom, Johanna G., Rezende, Suely M.

“…Summary Previous cross‐sectional studies showed that some patients with haemophilia A (HA) without inhibitor presented a pro‐inflammatory profile during factor…”
Get full text

The IL-10 polarized cytokine pattern in innate and adaptive immunity cells contribute to the development of FVIII inhibitors by Silveira, Amanda Co, Santana, Marcio Ap, Ribeiro, Isabella G, Chaves, Daniel G, Martins-Filho, Olindo A

“…Hemophilia A (HA) is an X-linked inherited bleeding disorder, resulting from a qualitative or quantitative deficiency of clotting factor VIII (FVIII)…”
Get full text

Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study by Jardim, Letícia L., Santana, Marcio P., Chaves, Daniel G., van der Bom, Johanna, Rezende, Suely M.

“…Up to 35% of patients with hemophilia A and 5% with hemophilia B develop neutralizing antibodies which can inhibit the therapeutic activity of factor…”
Get full text

Large Deletion in the Factor VIII Gene Is a Predictor of Immune Tolerance Induction Failure in People with Severe and Moderately-Severe Hemophilia a and High-Responding Inhibitors by Zuccherato, Luciana W., Souza, Renan P., Camelo, Ricardo M., Dias, Maise M., Santana, Marcio A. P., Jardim, Letícia L., Oliveira, Andrea G., Lorenzato, Claudia S., Cerqueira, Monica H., Franco, Vivian K. B., Ribeiro, Rosangela A., Etto, Leina Y., Roberti, Maria R. F., Callado, Fábia M. R. A., Cerqueira, Maria A. F., Pinto, Ieda S. S., Garcia, Andrea A., Anegawa, Tânia H., Neves, Daniele C. F., Tan, Doralice M., Chaves, Daniel G., Rezende, Suely M.

“…Introduction Immune tolerance induction (ITI) is a therapeutic approach to eradicate inhibitors against factor VIII (FVIII) in people with inherited hemophilia…”
Get full text

Inhibitor incidence in haemophilia A under exclusive use of a third‐generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study by Jardim, Letícia L., Bom, Johanna, Brommonschenkel, Christina C., Gouw, Samantha C., Rezende, Suely M.

Get full text

DARC polymorphism that abrogates erythrocyte Duffy antigen expression influences MCP-1 plasma level in HTLV-1 infected individuals but are not associated with HAM/TSP by Malta, Maria Clara FS, Sales, Camila C, Guimarães, Jacqueline C, Gonçalves, Poliane C, Chaves, Daniel G, Proietti, Anna Bárbara FC, Martins, Marina L

Get full text

Desenvolvimento de inibidores do fator VIII na hemofilia A Development of factor VIII inhibitors in hemophilia A by Daniel G. Chaves, Cibele V. Rodrigues

“…A hemofilia A é uma coagulopatia genética com herança recessiva ligada ao cromossomo X que afeta 1-2 a cada 10 mil indivíduos do sexo masculino nascidos vivos…”
Get full text

Desenvolvimento de inibidores do fator VIII na hemofilia A by Chaves, Daniel G., Rodrigues, Cibele V.

Get full text

Desenvolvimento de inibidores do fator VIII na hemofilia A by Chaves, Daniel G., Rodrigues, Cibele V.

“…A hemofilia A é uma coagulopatia genética com herança recessiva ligada ao cromossomo X que afeta 1-2 a cada 10 mil indivíduos do sexo masculino nascidos vivos…”
Get full text